In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


St Jude Medical's Angio-Seal STS Plus vascular closure device

This article was originally published in Clinica

Executive Summary

The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval for the Angio-Seal STS Plus vascular closure device, a product developed by St Jude Medical to help seal catheterisation sites. It is approved for both percutaneous peripheral and cardiac interventional catheterisation procedures, and enables physicians to seal the femoral artery punctures made during the surgery. The device incorporates a self-tightening suture, which St Paul, Minnesota-based St Jude claims is a significant advantage over its Angio-Seal Millennium vascular closure platform, which has been used in Japanese cath labs since 2004. The Ministry has also granted reimbursement approval for the device.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts